We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cangene Granted Exclusive U.S. Commercialization Rights for episil® by Camurus AB

News   Jul 10, 2012

 
Cangene Granted Exclusive U.S. Commercialization Rights for episil® by Camurus AB
 
 
Advertisement
 

RELATED ARTICLES

New Insights Into How Ovarian Cancer Grows and Evolves

News

In a paper published in the journal Cancer Research, researchers provide new insights into how ovarian cancer grows and evolves within a person.

READ MORE

Discovering the Strategies Tumor Cells Use To Evade Immune Attack

News

A new study has uncovered the strategies tumor cells use to evade immune system attack. The method developed for this work contributes to a better understanding of the "arms race" between immune defense and disease.

READ MORE

HDAC6 Halts the Spread of Triple-Negative Breast Cancer

News

The genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE